COMBINATION CHEMOTHERAPY WITH METHOTREXATE AND 5-FLUOROURACIL AND SURGERY FOR ADVANCED GASTRIC-CANCER WITH LIVER AND LYMPH-NODE METASTASES - A CASE-REPORT

被引:0
|
作者
KORENAGA, D [1 ]
TAKESUE, F [1 ]
TOH, Y [1 ]
MAEKAWA, S [1 ]
IKEDA, T [1 ]
SUGIMACHI, K [1 ]
机构
[1] KYUSHU UNIV,FAC MED,DEPT SURG 2,FUKUOKA 812,JAPAN
关键词
GASTRIC CANCER; METHOTREXATE; 5-FLUOROURACIL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on a case of advanced gastric cancer with multiple liver metastasis and lymph node metastases in a 65-year-old Japanese man. He was treated with sequential intravenous administration of moderate-dose methotrexate 1 (MTX) and 5-fluorouracil (5-FU) preoperatively. After eleven cycles of the combination chemotherapy, the findings of liver and lymph node metastases diminished dramatically and the tumor could be resected for a potential cure, using a total gastrectomy and combined hepatectomy. The resected specimen revealed a slightly elevated lesion and a somewhat shallow ulceration due to chemotherapy. Histologically, there was an infiltration of poorly differentiated adenocarcinomas with medullary structure in the muscularis mucosae with fibrous change. The liver was metastasized, but there was no evidence-of lymph node metastasis. We believe that combination chemotherapy of MTX and 5-FU can be effective against gastric cancer.
引用
收藏
页码:505 / 507
页数:3
相关论文
共 50 条
  • [41] Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan
    Kang, Byung Woog
    Kim, Jong Gwang
    Kwon, Oh-Kyoung
    Chung, Ho Young
    Yu, Wansik
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (18) : 5396 - 5402
  • [42] A PHASE-III RANDOMIZED STUDY OF 5-FLUOROURACIL AND CISPLATIN VERSUS 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN-C VERSUS 5-FLUOROURACIL ALONE IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    KIM, NK
    PARK, YS
    HEO, DS
    SUH, C
    KIM, SY
    PARK, KC
    KANG, YK
    SHIN, DB
    KIM, HT
    KIM, HJ
    KANG, WK
    SUH, CI
    BANG, YJ
    CANCER, 1993, 71 (12) : 3813 - 3818
  • [43] Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: A GISCAD study
    Zaniboni, A
    Labianca, R
    Martignoni, G
    Barni, S
    Vinci, M
    Vaghi, M
    Pirovano, M
    Facendola, G
    Marini, G
    Luporini, G
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (01) : 82 - 84
  • [44] Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer
    Baur, M.
    Horvath, M.
    Stattner, S.
    Schratter-Sehn, A.
    Horvath, B.
    Sellner, F.
    Hudec, M.
    Klimpfinger, M.
    Dittrich, C.
    Karner, J.
    ONCOLOGY LETTERS, 2010, 1 (01) : 189 - 194
  • [45] Adenocarcinoma of the duodenum with liver metastases - Complete remission and long-term survival with 5-fluorouracil chemotherapy - A case report
    Witham, M
    Harnett, PR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 305 - 306
  • [46] CHEMOTHERAPY IN GASTRIC-CANCER - AN ECONOMIC-EVALUATION OF THE FAM (5-FLUOROURACIL, ADRIAMYCIN, MITOMYCIN-C) VERSUS ELF (ETOPOSIDE, LEUCOVORIN, 5-FLUOROURACIL) REGIMENS
    NORUM, J
    ANGELSEN, V
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (05) : 455 - 459
  • [47] A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancer
    Kondo, K
    Sakamoto, J
    Nakazato, H
    Koike, A
    Kitoh, T
    Hachisuka, K
    Saji, S
    Yura, J
    Nimura, Y
    Hamajima, N
    Katoh, K
    Yamaguchi, A
    Miya, K
    Yamauchi, M
    Mizuno, I
    Nagino, M
    Takagi, H
    ONCOLOGY REPORTS, 2000, 7 (03) : 485 - 490
  • [48] A LONG-TERM SURVIVOR OF METASTATIC GASTRIC-CANCER TREATED BY CHEMOTHERAPY - CASE-REPORT
    NAGASE, K
    OHTSU, A
    SAITO, Y
    SAITO, M
    IKEYA, S
    ISHII, N
    NAKAYAMA, H
    HOSHINO, E
    SUGAI, Y
    WACHI, E
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (04) : 299 - 305
  • [49] Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan
    Chihiro Kondoh
    Shigenori Kadowaki
    Azusa Komori
    Yukiya Narita
    Hiroya Taniguchi
    Takashi Ura
    Masashi Ando
    Kei Muro
    Gastric Cancer, 2018, 21 : 1050 - 1057
  • [50] Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan
    Kondoh, Chihiro
    Kadowaki, Shigenori
    Komori, Azusa
    Narita, Yukiya
    Taniguchi, Hiroya
    Ura, Takashi
    Ando, Masashi
    Muro, Kei
    GASTRIC CANCER, 2018, 21 (06) : 1050 - 1057